Kabra Drugs informs about standalone financial results

15 Feb 2017 Evaluate

Kabra Drugs has informed about Standalone Financial Results, Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

7.19 0.00 (0.00%)
26-Mar-2024 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.